The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients

AIDS

Volumn 16, Issue 15, 2002, Pages 2087-2089

  Winston, Alan ^a   Mandalia, Sundhiya ^a   Pillay, Deenan ^a   Gazzard, Brian ^a   Pozniak, Anton ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; RNA DIRECTED DNA POLYMERASE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ARTICLE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS RESISTANCE;

ADENINE; ANTI-HIV AGENTS; DATABASES, FACTUAL; DIDEOXYNUCLEOSIDES; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0037131342     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200210180-00018     Document Type: Article

References (1)

1. Miller MD, Margot NA, Hertogs K, et al. Antiviral activity of tenofovir against nucleoside-resistant HIV samples. In: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, September 2000 [Abstract 2115].